Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Үндсэн зохиолчид: Rachel S Laufer (Зохиогч), Ranju Baral (Зохиогч), Andrea G Buchwald (Зохиогч), James D Campbell (Зохиогч), Flanon Coulibaly (Зохиогч), Fatoumata Diallo (Зохиогч), Moussa Doumbia (Зохиогч), Amanda J Driscoll (Зохиогч), Alison P Galvani (Зохиогч), Adama M Keita (Зохиогч), Kathleen M Neuzil (Зохиогч), Samba Sow (Зохиогч), Clint Pecenka (Зохиогч), Justin R Ortiz (Зохиогч), Meagan C Fitzpatrick (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...